ABSTRACT. Because of current interest in use of a com-used prophylactically to accelerate fetal lung maturation and bination of glucocorticoid and thyroid hormones for pre-prevent RDS in human newborns (2, 3) and in at least one vention of respiratory distress syndrome we examined the clinical study (4) thyroxine was also reported to be effective in effects of dexamethasone and triiodothyronine (T3), alone this regard. However, the findings in a recent multicenter study and in combination, on glycogen content and rates of fatty that glucocorticoids are not as efficacious in preventing RDS as acid and phosphatidylcholine synthesis in fetal rat lung. earlier believed and that its effects may be largely confined to The hormones were administered to the mothers on the 2 female infants (5) has led to interest in use of a combination of days before delivery on days 17-22 of gestation. Both glucocorticoids and thyroid hormone for prevention of RDS (6).
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hormones increased the rate of choline incorporation into Prior to such clinical use, however, it is desirable to have inforphosphatidylcholine, an index of surfactant synthesis, on mation on the interaction of these hormones in the acceleration day 20 just prior to the normal developmental surge but of lung maturation in animals. had no effect on this parameter on days 19, 21, or 22 .
Previous studies in animals have shown that a combination of There is a developmental increase in lung glycogen on days glucocorticoid and thyroid hormones is more effective than either 17-20 with a decrease thereafter and a developmental hormone alone in accelerating fetal lung maturation and stimuincrease in the rate of fatty acid synthesis between days 20 lating surfactant production. In a morphological study in the and 21. The increases in glycogen content and fatty acid fetal rat, Hitchcock (7) reported maximal acceleration of lung synthesis were accelerated by dexamethasone and pre-maturation when glucocorticoids and thyroxine were both presvented by T3 and when the hormones were administered ent. Similarly, a synergistic interaction between glucocorticoids together T3 antagonized the stimulatory effects of dexa-and thyroid hormone in stimulating synthesis of phosphatidylmethasone on these parameters. Both dexamethasone and choline and disaturated phosphatidylcholine, the major compo-T3 accelerated the normal developmental decrease in lung nent of pulmonary surfactant (I), was demonstrated in fetal rat glycogen later in gestation and the effects of the two lung in vivo (8, 9) and in fetal rat (10, 1 I), rabbit (12) , and hormones on this parameter were additive. The combina-human (1 3) lung in culture. tion of dexamethasone and T3 led to significantly smaller In addition to morphology and synthesis of surfactant phosfetuses and increased mortality late in gestation. These pholipids, lung maturation may also be assessed by other criteria. data show that glucocorticoid and thyroid hormones have An increase followed by a decrease in glycogen content is a opposite as well as common effects on parameters of fetal characteristic feature of fetal lung development (1, 14) . Although lung maturation. Although the relationship between there is a temporal relationship between the decrease in lung changes in lung glycogen or fatty acid synthesis and sur-glycogen and appearance of lamellar inclusion bodies (15) and factant production are not known the combination of hor-increased phosphatidylcholine synthesis (14) and it has been mones may be beneficial at certain gestational ages but speculated that glycogen may provide substrate for surfactant harmful at others. (Pediatr Res 20: 545-550, 1986) synthesis (16), a direct precursor-product relationship has not been established (1) . Nevertheless, hormones that accelerate lung Abbreviations maturation and stimulate surfactant production in the fetus also promote glycogen depletion (1). Glucocorticoids decreased lung T3, triiodothyronine glycogen in vivo in the fetal rabbit (17, 18) and mouse (19) while RDS, respiratory distress syndrome dexamethasone and thyroxine had a similar effect in cultured fetal rat lung explants (20) . The influence of a combination of these two hormones on this parameter of lung maturation, however, has not previously been reported. Glucocorticoids and thyroid hormone have been shown to A developmental increase in the rate of de novo fatty synthesis accelerate fetal lung maturation and stimulate surfactant pro-and in the activity of acetyl-CoA carboxylase with increasing duction in several animal species by biochemical, physiological, gestational age was reported in fetal rat lung (21) . A similar and morphological criteria (I). Glucocorticoids have long been developmental increase in the activity of fatty-acid synthase was Received October 24, 1985; accepted February 3, 1986. reported in fetal rabbit lung (22 Wilmington, MA) were injected intramuscularly with dexamethasone, T j in 0.9% NaCl, the two hormones together, or 0.9% NaCl (controls) on the 2 days prior to killing on 17-22 days gestation. (The day after mating was considered day I; term is 22 days.) Dexamethasone was administered once in the morning and once in the evening (1 mg/kg each injection) while T3 was injected only in the morning (7 mg/kg/day). The hormone doses used were those previously shown to optimally increase the rate of choline incorporation into phosphatidylcholine in fetal rat lung at 20 days gestation (8) . The mothers were killed by decapitation after concussion and the fetuses were delivered by cesarean section. Newborns were delivered spontaneously (on day 22) and kept with the mother for an additional day. These animals were not injected. Fetuses and newborns were killed by decapitation. Lungs from two to three animals in each litter were rapidly excised and immediately frozen in dry ice-acetone for glycogen assay. The remaining fetuses were pooled, the average body weight was obtained, and the lungs were excised and placed in chilled Krebs-Ringer phosphate buffer (pH 7.4) for subsequent measurement of fatty acid synthesis or choline incorporation into phosphatidylcholine.
Fatty acid synthesis. Fatty acid synthesis was assessed by
measuring the rate of incorporation of from 3H20 into total lipid fatty acid in lung slices. Use of 'Hz0 rather than acetate or other substrate overcomes problems associated with differences in substrate pool size (25) . The method was a modification of that described by Maniscalco el al. (21) . Slices (0.5 mm thick) were prepared from the freshly excised lungs with a McIlwain tissue chopper (Brinkmann, Westbury, NY) and incubated in 2 ml Krebs-Ringer phosphate buffer (pH 7.4) containing 5 mM glucose in capped 20 ml scintillation vials in a shaking water bath at 37" C. Lung tissue from each litter was distributed among two to four vials (3-13 mg protein each). After a 10-min preincubation period 3H20 (0.5 mCi) was added and the incubation continued. The reaction was stopped after 0 or 2 h by addition of 7.5 ml chilled 0.9% NaCl. The tissue was further washed with additional aliquots of saline and finally homogenized in 1.8 ml. An aliquot of the homogenate was removed for protein assay by the method of Lowry et al. (26) and a further aliquot (1.6 ml) for lipid extraction with chloroform and methanol by the method of Bligh and Dyer (27) . The total lipids were evaporated to dryness under N2, 2 ml 14% boron trifluoride in methanol (Sigma, St Louis, MO) were added, and the mixture was incubated at 85" C for 1 h. On cooling to room temperature, 1 ml saturated NaCl was added and the fatty acid methyl esters were extracted with two 4-ml aliquots of hexane and purified by thinlayer chromatography on LK5D silica gel plates (Whatman, Clifton, NJ) in hexane:diethyl ether:acetic acid (80:20: 1, v/v/v.) The fatty acid methyl ester band was detected by exposure to iodine vapor and identified by comparison with standards. Radioactivity was measured directly on the gel by liquid scintillation counting in Aqvasol (New England Nuclear, Boston, MA) containing 3% water. The counting efficiency was 45%. The amount of radioactivity in the incubation medium was also measured to obtain the initial specific activity. Under these conditions the rate of 3H incorporation into fatty acid was linear with time for at least 3 h.
Rate of choline incorporation into phosphatidylcholine.
The rate of [methyl-'4C]choline incorporation into phosphatidylcholine in lung slices was measured in Krebs-Ringer phosphate buffer as described previously (17, 19) . Because of possible differences in the intracellular pool sizes of choline or phosphorylated choline intermediates it is possible that this measurement is not a true reflection of phosphatidylcholine synthesis. Nevertheless in developmental and hormonal studies on the fetal lung the rate of choline incorporation into phosphatidylcholine in slices has shown good correlation with increased mass of phosphatidylcholine and with increased cholinephosphate cytidylyltransferase activity (1, 14) .
Glycogen assay. Glycogen was assayed as described previously (28) . In this procedure glycogen breakdown is coupled to generation of NADPH which is measured fluorometrically (29) . The rapidly frozen lungs were stored at -70" C until assayed.
Chemicals. Radiochemicals 
RESULTS
Developmental changes in glycogen content and in rates of fatty acid synthesis and choline incorporation into phosphatidylcholine in fetal and newborn rat lung are shown in Figure 1 . There was an increase in lung glycogen up to day 20, when the highest level was reached, followed by a decrease. The rate of fatty acid synthesis changed little between 19 and 20 days, then increased more than 50% to reach a plateau at 21-22 days and decreased to less than the 19-to 20-day rate in the newborn period. The rate of choline incorporation into phosphatidylcholine more than tripled between 19-20 days gestation and 1 day after birth. These profiles are similar to those previously reported for glycogen content (28, (30) (31) (32) and phosphatidylcholine synthesis (28, (33) (34) (35) (36) in the rat. Similar developmental profiles have been reported in other species (1, 14) . In one previous study (2 1) a developmental profile for rat lung de novo fatty acid synthesis similar to that in Figure 1 was also reported.
The effects of dexamethasone and T3, alone and in combination, on fatty acid synthesis in developing rat lung are shown in Table I . The rate of fatty acid synthesis was significantly increased by dexamethasone on day 20 but unaffected by this hormone at the other ages examined. On days 21 and 22 fatty acid synthesis was significantly lower in the T,-treated group than in the controls. Thus the developmental increase in fatty acid synthesis which occurs normally on day 2 1 was accelerated by the glucocorticoid and prevented by the thyroid hormone. Fatty acid synthesis in the combined hormone-treated group was significantly different from that in both the control and dexamethasone-treated groups on days 20 and 21. Thus T j antagonized both the normal developmental increase in fatty acid synthesis and that induced by dexamethasone.
The effects of the hormones on the glycogen content of the fetal lung are shown in Table 2 . Compared to the controls, dexamethasone increased lung glycogen on days 17-19 and decreased it on days 2 1-22. Thus dexamethasone increased lung glycogen at the period in gestation when there is a normal developmental increase in this parameter and decreased it when it is normally decreasing (Fig. 1) . Since the peak in lung glycogen occurred on day 19 in the glucocorticoid-treated group but on day 20 in the controls (Fig. l) , the hormone accelerated lung maturation by one day as determined by this parameter. T3, on the other hand, had no effect on lung glycogen on days 17 and 18 but decreased it on days 19-22. This hormone, therefore, prevented the normal developmental increase in lung glycogen between days 18 and 20, although not between days 17 and 18, and accelerated the developmental decrease which normally occurs after day 20 (Fig. 1) . When compared to controls, the two hormones together increased lung glycogen on days 17 and 18 and decreased it on days 19-22. However, the increase on days 17 and 18 was less than that produced by dexamethasone alone suggesting that this effect of the glucocorticoid was also antagonized by T3. The increase produced by dexamethasone alone on day 19 was reversed by T3 as there was less lung glycogen in the Table I . Effect o f hormones on fa, combined hormone-treated group than in the controls at this age. Although dexamethasone alone had no effect on day 20, in combination with T3 it decreased glycogen to a greater extent than did T3 alone. The combination also decreased lung glycogen to a greater extent than either hormone alone on day 2 1. Thus the effects of dexamethasone and T3 were antagonistic at the period in gestation when glycogen is normally increasing but additive when lung glycogen is normally decreasing.
Dexamethasone and T3 increased the rate of choline incorporation into phosphatidylcholine by 62 and 30%, respectively, on day 20 (Table 3 ). The effect of the two hormones combined on this parameter was not examined since in a previous study using the same experimental model it was reported to be additive (8) . The effects of dexamethasone and T3 on phosphatidylcholine synthesis were highly specific with respect to gestational age. Stimulation occured only on the day prior to the normal developmental surge in this parameter (Fig. I) . Thus the effect was seen on day 20 but not on days 19, 2 1, or 22. It is possible that the lack of stimulation on day 19 was due to a high control value since the rate of choline incorporation into phosphatidylcholine decreased in the control groups between 19 and 20 days (p < 0.005, t test) while in other studies it increased during this period (33) (34) (35) (36) . A decrease in the rates of choline and glycerol incorporation into phosphatidylcholine between days 18 and 19 was, however, reported in fetal rat lung (36) .
The effects of the hormones on fetal weight and mortality are shown in Table 4 . As in other studies in the rat (37) and rabbit (38) , the fetuses from the glucocorticoid-treated animals weighed less than those from the controls. However, the differences were only statistically significant on days 18, 21, and 22. The T3 and combined hormone-treated groups also weighed less than the controls on days 2 1 and 22. On day 21 the group treated with both hormones weighed 30% less than the controls and 24% less than those treated with either hormone alone.
There was one dead fetus among the controls on day 20 (0.4% of the total) and none in the dexamethasone-treated groups (Table 4 ). There was increased mortality in the T3-treated groups: 1, 5.7, and 3.4% on days 20, 21, and 22, respectively. The most striking increase in mortality, however, was in the combined hormone-treated group at 22 days when 72.3% of the fetuses were dead on delivery. In this group 2.4% were dead on day 2 1 but all were alive on days 17-20.
DISCUSSION
These data show that glucocorticoid and thyroid hormones have some effects in common and some opposing effects on parameters of lung maturation in the fetal rat. Both hormones accelerate the normal developmental increase in the rate of choline incorporation into phosphatidylcholine and the normal developmental decrease in lung glycogen late in gestation. However, while the glucocorticoid also accelerates the normal developmental increase in lung glycogen earlier in gestation this increase is largely prevented by the thyroid hormone. Similarly, the normal developmental increase in fatty acid synthesis is accelerated by the glucocorticoid and prevented by the thyroid rtv acid synthesis in fetal rat lung t Significantly different from control group.
-$ Significantly different from control, dexamethasone, and T3-treated groups.
4 Significantly different from control and dexamethasone-treated groups. (5) 20 213+11 (7) 345&31 (8) hormone. When the two hormones are administered together their effects on glycogen depletion and, as reported earlier (8), on phosphatidylcholine synthesis are additive but the stimulatory effects of the glucocorticoid on glycogen and on fatty acid synthesis are antagonized by the thyroid hormone.
Further studies are needed to elucidate the mechanism of these hormonal effects. It will be of interest to determine if the inhibitory effect of thyroid hormone on glycogen increase for instance is due to inhibition of synthesis or increased catabolism. Preliminary studies indicate that the increase in fatty acid synthesis produced by dexamethasone is accompanied by increased fattyacid synthase activity (39) .
Numerous studies in several species have shown that glucocorticoid and thyroid hormones stimulate fetal surfactant production by a variety of criteria (1) . In previous studies in fetal rat, rabbit, and human lung, the actions of glucocorticoid and thyroid hormones were generally reported to be additive when indices of surfactant production were measured (8-13). Betamethasone and thyroxine also had a marked additive effect on depletion of fetal heart glycogen when administered to the pregnant rabbit (40) . Thyroxine, however, was reported to antagonize the stimulatory effect of cortisol on incorporation of glucose and acetate into phosphatidylcholine and phosphatidylglycerol in cultured adult rat type I1 pneumocytes (41), the cellular source of surfactant within the lung (I). Cortisol also increased the rates of incorporation of choline, glycerol, and palmitate into phosphatidylcholine but these effects were not antagonized by thyroxine. Since palmitate incorporation was not antagonized, the antagonistic effect of thyroxine on acetate incorporation in that study (41) could indicate an effect at the level of fatty acid synthesis. In contrast, Ballard et al. (12) reported that the stimulatory effects of T3 and dexamethasone on rates of glucose, glycerol, and acetate incorporation into phosphatidylcholine in explants of fetal rabbit lung were additive.
In the present study we used the rate of choline incorporation into phosphatidylcholine in lung slices as an index of surfactant synthesis. Although not a specific measurement of surfactant synthesis the rate of choline incorporation into phosphatidylcholine generally shows good correlation with other indices of surfactant production in the fetal lung (1, 14) . Dexamethasone and T3 both increased the rate of choline incorporation into phosphatidylcholine but only on the one day prior to the normal developmental surge in this parameter. That the stimulatory effect of glucocorticoids on fetal lung phosphatidylcholine synthesis was highly specific with respect to gestational age was also reported in other in vivo and in vitro studies in the fetal rat (37, 42) and rabbit (l7,43). Glucocorticoids were reported to be most effective in preventing RDS in human infants delivered at 30-34 wk gestation (5) . That the effect of hormones should be confined to a relatively narrow gestational age range is not surprising if they accelerate development of a normally occurring process.
Although glucocorticoids (17) (18) (19) (20) , thyroid hormone (20), estrogen (44, 45) , and aminophylline (46, 47) have previously been reported to accelerate the normal developmental decrease in lung glycogen, an acceleration of the earlier increase in lung glycogen was reported in only one previous study. Alescio and Dani (48) reported that the glycogen content of 1 1-day fetal mouse lung explants was increased when cultured in the presence of cortisol for 48 h. Effects of hormones on fatty acid synthesis in developing fetal lung have not been extensively examined. Maniscalco et al. (23) reported that dexamethasone increased the rate of 3H20 incorporation into fatty acid in fetal rabbit lung explants in vitro. In contrast, cortisol was reported to decrease the rate of de novo lung fatty acid synthesis in the same species in vivo (49) . That study, however, differed from the present study and that of Maniscalco et al. (23) in at least two respects. First, incorporation of radioactivity from 14C-acetylCoA rather than 3H20 was used to assess fatty acid synthesis so hormone-induced changes in the pool size of acetylCoA could account for the observed effect. Second, since the fetuses were directly injected with the hormone the inhibition might have been due to the resulting stress.
Although direct extrapolation of these findings in the fetal rat to the human infant is not warranted it is nevertheless of interest to consider whether they have any relevence to possible clinical use of a combination of glucocorticoid and thyroid hormones for prevention of RDS. Although phosphatidylcholine synthesis was increased by the hormones only on day 20, lung maturation as determined by glycogen content was affected at all ages examined. However, while there is a temporal relationship between fetal lung glycogen depletion and increased phosphatidylcholine synthesis in several species (1, 14) it has not been proven that glycogen is a precursor of surfactant phospholipids (1) . The relationship between the earlier developmental increase in lung glycogen and surfactant production is even more obscure. Similarly, although fatty acids are obligatory components of surfactant the relative contributions of fatty acids from de novo synthesis in the lung and from extrapulmonary sources to surfactant phospholipdis are not definitely established (2 1, 50 ). In addition, in the present study we measured synthesis of total lipid fatty acids rather than those in specific phospholipid molecular species. Thus, although the developmental increase in fatty acid 3 Fetuses dead on delivery/total number of fetuses. All fetuses were alive when number is not indicated. 5 Significantly different from all other groups. synthesis as well as that induced by dexamethasone coincided with the increases in phosphatidylcholine synthesis these data do not prove that such fatty acids are incorporated into surfactant. Since whole lung tissue was used in this study it is possible that not all of the effects occur in the same cell type and may not all be directly related to surfactant production. Thus, the antagonistic effects of thyroid hormone on both the developmental and glucocorticoid-induced increases in glycogen and fatty acid synthesis may have little relevence to use of these two hormones in combination for prevention of RDS. On the other hand, although a deficiency in surfactant is undoubtedly a major factor in the etiology of RDS, immaturity in other aspects of lung development may also have a bearing on it. Changes in lung elastin, for instance, were reported in infants with RDS ( 5 1) while glucocorticoids were reported to influence connective tissue in the fetal monkey (52) , to increase synthesis of sulfated glycoconjugates in human fetal lung explants (53) , and to increase antioxidant enzyme activities in fetal rat lung (37) . Possible deleterious effects of combined hormone therapy on nonsurfactant aspects of fetal lung development should therefore be considered. It is possible that the hormones have beneficial effects at certain stages of development and deleterious effects at others. Thus the combination of hormones might be of benefit at the stage in lung development when glycogen is being depleted and surfactant synthesis is increasing but harmful at an earlier stage.
Since the litters treated with T3 and, to a greater extent, T3 together with dexamethasone had increased mortality as well as smaller fetuses late in gestation the issue of toxicity in combined hormone treatment ought to be considered too. In this study we used a dose of T3 which was previously shown to optimally stimulate phosphatidylcholine synthesis in fetal rat lung at 20 days gestation (8) but did not determine if this dose was optimal at the other ages examined and did not measure hormone levels in the fetal blood. Whether a lower dose and/or a different treatment regimen would retain the beneficial effects while eliminating those that are harmful remains to be determined in the rat and other species.
